SCHEMBL7744170

SCHEMBL7744170

O=C(Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1cccnc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.45
F12 P00748 1/20 0.45
KDR P35968 5/20 0.44
FLT1 P17948 1/20 0.44
FLT4 P35916 1/20 0.44
POLB P06746 3/20 0.43
PSMD14 O00487 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
PRKD3 O94806 1/20 0.43
ABL1 P00519 1/20 0.43
PRKCG P05129 1/20 0.43
PRKCB P05771 1/20 0.43
PDGFRB P09619 1/20 0.43
BCR P11274 1/20 0.43
SRC P12931 1/20 0.43
PDGFRA P16234 1/20 0.43
PRKCA P17252 1/20 0.43
PRKCH P24723 1/20 0.43
PRKCI P41743 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746601 0.91 KDR (0.53) KDRFLT1FLT4POLBNPC1
SCHEMBL7739016 0.88 KDR (0.56) KDRFLT1FLT4POLBABL1
SCHEMBL7744061 0.85 KDR (0.50) KDRFLT1FLT4POLBNPC1
SCHEMBL7985540 0.85 KDR (0.47) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7739071 0.84 KDR (0.43) KDRFLT1FLT4POLBNPC1
SCHEMBL7744167 0.84 HDAC1 (0.53) F2F12KDRFLT1FLT4
SCHEMBL7746655 0.84 KDR (0.43) KDRFLT1FLT4NPC1SMN1; SMN2
SCHEMBL7744087 0.83 KDR (0.46) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7746570 0.83 KDR (0.49) KDRFLT1FLT4POLBNPC1
SCHEMBL7738996 0.83 KDR (0.52) KDRFLT1FLT4POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed